Get started
Author

Τατιάνα Τζένου

Observed names: T Tzenou, T. Tzenou, Tatiana K Tzenou, Tatiana K. Tzenou, Tatiana Tzenou, Tzenou T, Tzenou, Tatiana
ORCID: 0000-0003-3281-5303
Observed ORCID: 0000-0003-3281-5303
OpenAlex ID: A5014713745
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
2007 · Marie‐Christine Kyrtsonis, Theodoros P. Vassilakopoulos, et al. · British Journal of Haematology · 129
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study
2014 · Panagiotis Baliakas, Anastasia Hadzidimitriou, et al. · The Lancet Haematology · 113
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2
2013 · J C Strefford, L-A Sutton, et al. · Leukemia · 104
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations
2015 · Panagiotis Baliakas, Andreas Agathangelidis, et al. · Blood · 83
PDF
Re‐evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents
2012 · Dimitrios Maltezas, Meletios A. Dimopoulos, et al. · Hematological Oncology · 65
Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma
2012 · Efstathios Koulieris, Panayiotis Panayiotidis, et al. · Experimental Hematology and Oncology · 43
PDF
Staging Systems and Prognostic Factors as a Guide to Therapeutic Decisions in Multiple Myeloma
2009 · Marie-Christine Kyrtsonis, Dimitrios Maltezas, et al. · Seminars in Hematology · 39
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
2017 · Aliki Xochelli, Panagiotis Baliakas, et al. · Clinical Cancer Research · 36
Non-gastric extra-nodal marginal zone lymphomas–a single centre experience on 76 patients
2008 · Christina Kalpadakis, Gerassimos A. Pangalis, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 35
Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse
2012 · Xenofon Papanikolaou, Panagiotis Repousis, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 34
Differential Diagnosis of Waldenström's Macroglobulinemia and Other B-Cell Disorders
2005 · Gerassimos A. Pangalis, Maria-Christina Kyrtsonis, et al. · Clinical Lymphoma · 34
Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib
2008 · K. Anargyrou, E. Terpos, et al. · Haematologica · 30
PDF
Serum levels of soluble syndecan-1 in Hodgkin's lymphoma.
2006 · Theodoros P Vassilakopoulos, Marie-Christine Kyrtsonis, et al. · PubMed · 29
CD138 Expression Helps Distinguishing Waldenström's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL)
2011 · Marie-Christine Kyrtsonis, Georgia Levidou, et al. · Clinical Lymphoma Myeloma & Leukemia · 26
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy
2017 · Panagiotis Baliakas, Mattias Mattsson, et al. · Haematologica · 23
Mutation analysis of IgVH genes in splenic marginal zone lymphomas: correlation with clinical characteristics and outcome.
2009 · Christina Kalpadakis, Gerassimos A Pangalis, et al. · PubMed · 20
Is leishmaniasis an “unusual suspect” of infection in allogeneic transplantation?
2014 · A. Komitopoulou, T. Tzenou, et al. · Transplant Infectious Disease · 17
Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia
2014 · Marie-Christine Kyrtsonis, Katerina Sarris, et al. · BioMed Research International · 16
PDF
EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapy
2024 · Eleni Gavriilaki, Ifigeneia Tzannou, et al. · Blood Vessels Thrombosis & Hemostasis · 13
Easix Indices Predict CRS and Overall Survival in Adult CAR-T Cell Recipients
2023 · Eleni Gavriilaki, Ifigeneia Tzannou, et al. · Blood · 10
Clonotypic Analysis of Immunoglobulin Heavy Chain Sequences in Patients with Waldenström’s Macroglobulinemia: Correlation withMYD88L265P Somatic Mutation Status, Clinical Features, and Outcome
2014 · Loizos Petrikkos, Marie-Christine Kyrtsonis, et al. · BioMed Research International · 10
PDF
Assessment of bortezomib induced peripheral neuropathy in multiple myeloma by the reduced Total Neuropathy Score
2014 · Chrysothea K. Zaroulis, Konstantinos Chairopoulos, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 9
Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia
2013 · Katerina Sarris, Dimitrios Maltezas, et al. · Advances in Hematology · 9
PDF
Management strategies for CAR-T cell therapy-related toxicities: results from a survey in Greece
2025 · Eleni Gavriilaki, Ifigeneia Tzannou, et al. · Frontiers in Medicine · 7
PDF
Quantification of Serum IgMκ and IgMλ In Patients with Waldenstrom's Macroglobulinemia (WM) at Diagnosis and During Disease Course; Clinical Correlations
2010 · Efstathios Koulieris, Marie-Christine Kyrtsonis, et al. · Blood · 6
Works count: 90
Citation count: 965
H-index: 17
I10-index: 21
Year
Topic
Type